Literature DB >> 14697372

Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT.

S L Smith1, P S Rajan.   

Abstract

Pancreatic adenocarcinoma is the fourth most frequent cause of cancer-related death. The incidence is increasing and the overall survival has altered little in recent years. Moreover, patients usually present late with inoperable disease and curative resection by standard pancreatico-duodenectomy (Whipple's procedure) is associated with significant morbidity. It should only be attempted in that small group of patients lacking radiological evidence of advanced disease. Despite the recent advances in body magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS), computed tomography (CT) is the mainstay of staging in most centres and the recent development of multidetector CT machines (MDCT) has raised hope of an improvement in preoperative staging. This review focuses on the CT of pancreatic adenocarcinoma with particular emphasis on examination technique and on those criteria that determine resectability.

Entities:  

Mesh:

Year:  2004        PMID: 14697372     DOI: 10.1016/j.crad.2003.07.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

1.  The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.

Authors:  Lujaien A Kadhim; Avani S Dholakia; Joseph M Herman; Richard L Wahl; Muhammad A Chaudhry
Journal:  J Radiat Oncol       Date:  2013-10-30

2.  Assessment of pancreatic malignancy with laparoscopy and intraoperative ultrasound.

Authors:  H Doucas; C D Sutton; A Zimmerman; A R Dennison; D P Berry
Journal:  Surg Endosc       Date:  2006-12-20       Impact factor: 4.584

3.  Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results.

Authors:  Miriam Klauss; Max Schöbinger; Ivo Wolf; Jens Werner; Hans-Peter Meinzer; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

4.  Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker.

Authors:  Chuanli Ren; Chongxu Han; Daxin Wang; Xiaohang Zhao; Guangfu Jin; Hongbing Shen
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

5.  Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features.

Authors:  Jill C Moore; Joel S Bentz; Kristen Hilden; Douglas G Adler
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

6.  Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.

Authors:  T Di Valentin; T Asmis; J Asselah; F Aubin; N Aucoin; S Berry; J Biagi; C M Booth; R Burkes; N Coburn; B Colwell; C Cripps; L A Dawson; M Dorreen; D Frechette; R Goel; S Gray; N Hammad; D Jonker; P Kavan; J Maroun; S Nanji; D Roberge; B Samson; M Seal; W Shabana; M Simunovic; S Snow; M Tehfe; M Thirlwell; E Tsvetkova; M Vickers; T Vuong; R Goodwin
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

7.  Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.

Authors:  Piero Boraschi; Francescamaria Donati; Roberto Gigoni; Davide Caramella; Ugo Boggi; Fabio Falaschi; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2006-01-19       Impact factor: 5.315

Review 8.  Clinical approach to the patient with a solid pancreatic mass.

Authors:  Reinhold Függer; Odo Gangl; Uwe Fröschl
Journal:  Wien Med Wochenschr       Date:  2014-02-28

Review 9.  Approaches to localized pancreatic cancer.

Authors:  Martin Loos; Jörg Kleeff; Helmut Friess; Markus W Büchler
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

10.  Indicative findings of pancreatic cancer in prediagnostic CT.

Authors:  Sung Soo Ahn; Myeong-Jin Kim; Jin-Young Choi; Hye-Suk Hong; Yong Eun Chung; Joon Seok Lim
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.